Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 19 de 19
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Expert Opin Drug Discov ; 16(12): 1483-1495, 2021 12.
Artículo en Inglés | MEDLINE | ID: mdl-34191664

RESUMEN

IntroductionLeukotriene A4 hydrolase (LTA4H) is the final and rate limiting enzyme regulating the biosynthesis of leukotriene B4 (LTB4), a pro-inflammatory lipid mediator implicated in a large number of inflammatory pathologies. Inhibition of LTA4H not only prevents LTB4 biosynthesis but also induces a lipid mediator class-switch within the 5-lipoxygenase pathway, elevating biosynthesis of the anti-inflammatory lipid mediator Lipoxin A4. Ample preclinical evidence advocates LTA4H as attractive drug target for the treatment of chronic inflammatory diseases.Areas coveredThis review covers details about the biochemistry of LTA4H and describes its role in regulating pro- and anti-inflammatory mediator generation. It summarizes recent efforts in medicinal chemistry toward novel LTA4H inhibitors, recent clinical trials testing LTA4H inhibitors in pulmonary inflammatory diseases, and potential reasons for the discontinuation of former development programs.Expert opinionGiven the prominent role of LTB4 in initiating and perpetuating inflammation, LTA4H remains an appealing drug target. The reason former attempts targeting this enzyme have not met with success in the clinic can be attributed to compound-specific liabilities of first-generation inhibitors and/or choice of target indications to test this mode of action. A new generation of highly potent and selective LTA4H inhibitors is currently undergoing clinical testing in indications with a strong link to LTB4 biology.


Asunto(s)
Inhibidores Enzimáticos , Epóxido Hidrolasas , Antiinflamatorios/farmacología , Descubrimiento de Drogas , Inhibidores Enzimáticos/farmacología , Epóxido Hidrolasas/metabolismo , Humanos
2.
J Med Chem ; 64(4): 1889-1903, 2021 02 25.
Artículo en Inglés | MEDLINE | ID: mdl-33592148

RESUMEN

The cytosolic metalloenzyme leukotriene A4 hydrolase (LTA4H) is the final and rate-limiting enzyme in the biosynthesis of pro-inflammatory leukotriene B4 (LTB4). Preclinical studies have validated this enzyme as an attractive drug target in chronic inflammatory diseases. Despite several attempts, no LTA4H inhibitor has reached the market, yet. Herein, we disclose the discovery and preclinical profile of LYS006, a highly potent and selective LTA4H inhibitor. A focused fragment screen identified hits that could be cocrystallized with LTA4H and inspired a fragment merging. Further optimization led to chiral amino acids and ultimately to LYS006, a picomolar LTA4H inhibitor with exquisite whole blood potency and long-lasting pharmacodynamic effects. Due to its high selectivity and its ability to fully suppress LTB4 generation at low exposures in vivo, LYS006 has the potential for a best-in-class LTA4H inhibitor and is currently investigated in phase II clinical trials in inflammatory acne, hidradenitis suppurativa, ulcerative colitis, and NASH.


Asunto(s)
Aminobutiratos/uso terapéutico , Antiinflamatorios/farmacología , Inhibidores Enzimáticos/uso terapéutico , Epóxido Hidrolasas/antagonistas & inhibidores , Piridinas/uso terapéutico , Aminobutiratos/síntesis química , Aminobutiratos/farmacocinética , Animales , Antiinflamatorios/síntesis química , Antiinflamatorios/farmacocinética , Artritis Experimental/tratamiento farmacológico , Perros , Descubrimiento de Drogas , Inhibidores Enzimáticos/síntesis química , Inhibidores Enzimáticos/farmacocinética , Femenino , Humanos , Inflamación/tratamiento farmacológico , Masculino , Ratones Endogámicos C57BL , Estructura Molecular , Piridinas/síntesis química , Piridinas/farmacocinética , Ratas Wistar , Relación Estructura-Actividad
3.
ACS Chem Biol ; 15(10): 2636-2648, 2020 10 16.
Artículo en Inglés | MEDLINE | ID: mdl-32880443

RESUMEN

Assays drive drug discovery from the exploratory phases to the clinical testing of drug candidates. As such, numerous assay technologies and methodologies have arisen to support drug discovery efforts. Robust identification and characterization of tractable chemical matter requires biochemical, biophysical, and cellular approaches and often benefits from high-throughput methods. To increase throughput, efforts have been made to provide assays in miniaturized volumes which can be arrayed in microtiter plates to support the testing of as many as 100,000 samples/day. Alongside these efforts has been the growth of microtiter plate-free formats with encoded libraries that can support the screening of billions of compounds, a hunt for new drug modalities, as well as emphasis on more disease relevant formats using complex cell models of disease states. This review will focus on recent developments in high-throughput assay technologies applied to identify starting points for drug discovery. We also provide recommendations on strategies for implementing various assay types to select high quality leads for drug development.


Asunto(s)
Descubrimiento de Drogas/métodos , Compuestos Orgánicos/análisis , Ensayos Analíticos de Alto Rendimiento , Humanos , Bibliotecas de Moléculas Pequeñas/análisis
4.
ChemMedChem ; 15(24): 2448-2461, 2020 12 15.
Artículo en Inglés | MEDLINE | ID: mdl-32544308

RESUMEN

We describe here our efforts to develop a PET tracer for imaging GluN2A-containing NMDA receptors, based on a 5H-thiazolo[3,2-α]pyrimidin-5-one scaffold. The metabolic stability and overall properties could be optimized satisfactorily, although binding affinities remained a limiting factor for in vivo imaging. We nevertheless identified 7-(((2-fluoroethyl)(3-fluorophenyl)amino)-methyl)-3-(2-(hydroxymethyl)cyclopropyl)-2-methyl-5H-thiazolo-[3,2-α]pyrimidin-5-one ([18 F]7b) as a radioligand providing good-quality images in autoradiographic studies, as well as a tritiated derivative, 2-(7-(((2-fluoroethyl)(4-fluorophenyl)amino)methyl)-2-methyl-5-oxo-5H-thiazolo[3,2-α]pyrimidin-3-yl)cyclopropane-1-carbonitrile ([3 H2 ]15b), which was used for the successful development of a radioligand binding assay. These are valuable new tools for the study of GluN2A-containing NMDA receptors, and for the optimization of allosteric modulators binding to the pharmacophore located at the dimer interface of the GluN1-GluN2A ligand-binding domain.


Asunto(s)
Pirimidinonas/química , Radiofármacos/química , Receptores de N-Metil-D-Aspartato/metabolismo , Tiazoles/química , Animales , Encéfalo/diagnóstico por imagen , Perros , Radioisótopos de Flúor/química , Células de Riñón Canino Madin Darby , Masculino , Ratones , Microsomas Hepáticos/metabolismo , Tomografía de Emisión de Positrones , Pirimidinonas/síntesis química , Pirimidinonas/metabolismo , Radiofármacos/síntesis química , Radiofármacos/metabolismo , Ratas Wistar , Tiazoles/síntesis química , Tiazoles/metabolismo , Tritio/química
5.
Sci Transl Med ; 11(497)2019 06 19.
Artículo en Inglés | MEDLINE | ID: mdl-31217337

RESUMEN

Increased airway hyperresponsiveness and epithelial remodeling in asthmatic LTA4H-KO mice may be mediated by CysLTs rather than elevated tripeptide PGP.


Asunto(s)
Asma , Hipersensibilidad Respiratoria , Animales , Matriz Extracelular , Ratones
6.
Sci Rep ; 7(1): 13591, 2017 10 19.
Artículo en Inglés | MEDLINE | ID: mdl-29051536

RESUMEN

Leukotriene A4 Hydrolase (LTA4H) is a bifunctional zinc metalloenzyme that comprises both epoxide hydrolase and aminopeptidase activity, exerted by two overlapping catalytic sites. The epoxide hydrolase function of the enzyme catalyzes the biosynthesis of the pro-inflammatory lipid mediator leukotriene (LT) B4. Recent literature suggests that the aminopeptidase function of LTA4H is responsible for degradation of the tripeptide Pro-Gly-Pro (PGP) for which neutrophil chemotactic activity has been postulated. It has been speculated that the design of epoxide hydrolase selective LTA4H inhibitors that spare the aminopeptidase pocket may therefore lead to more efficacious anti-inflammatory drugs. In this study, we conducted a high throughput screen (HTS) for LTA4H inhibitors and attempted to rationally design compounds that would spare the PGP degrading function. While we were able to identify compounds with preference for the epoxide hydrolase function, absolute selectivity was not achievable for highly potent compounds. In order to assess the relevance of designing such aminopeptidase-sparing LTA4H inhibitors, we studied the role of PGP in inducing inflammation in different settings in wild type and LTA4H deficient (LTA4H KO) animals but could not confirm its chemotactic potential.  Attempting to design highly potent epoxide hydrolase selective LTA4H inhibitors, therefore seems to be neither feasible nor relevant.


Asunto(s)
Inhibidores Enzimáticos/química , Inhibidores Enzimáticos/farmacología , Epóxido Hidrolasas/antagonistas & inhibidores , Epóxido Hidrolasas/química , Oligopéptidos/metabolismo , Prolina/análogos & derivados , Aminopeptidasas/metabolismo , Animales , Antiinflamatorios no Esteroideos/química , Antiinflamatorios no Esteroideos/farmacología , Dominio Catalítico , Cristalografía por Rayos X , Diseño de Fármacos , Epóxido Hidrolasas/metabolismo , Ensayos Analíticos de Alto Rendimiento/métodos , Humanos , Ratones Endogámicos BALB C , Ratones Endogámicos C57BL , Ratones Noqueados , Neutrófilos/metabolismo , Neutrófilos/patología , Neumonía/metabolismo , Neumonía/patología , Prolina/metabolismo , Relación Estructura-Actividad
7.
J Lab Autom ; 18(3): 245-50, 2013 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-23355542

RESUMEN

Although developments in liquid dispensers have made the use of 1536-well plates for high-throughput screening (HTS) standard, there is still a gap in dispenser technology for performing matrix experiments with several components. Experiments such as those performed during assay development and enzymological studies are therefore still performed by manual pipetting in lower-density plates. We have evaluated a new dispenser, the Certus liquid dispenser (Gyger Fluidics GmbH, Switzerland), that is capable of flexible dispensing in 1536-well format, with a dead volume of less than 200 µL. Taking advantage of the precision of the dispenser for volumes down to 50 nL, we have created concentration gradients on plates by dispensing different volumes of reagent and then backfilling with buffer. Using this method and the flexibility of the dispenser software, we have performed several multidimensional experiments varying two to three components, including an assay development for an HTS, a mode of inhibition study, and a cofactor optimization, in which we determined 32 KM values. Overall, the flexibility of the plate layout for multiple components, the accuracy to dispense volumes ranging 2 log orders, and minimal reagent usage enable this dispenser for complex biochemical experiments.


Asunto(s)
Enzimas/química , Ensayos Analíticos de Alto Rendimiento/instrumentación , Técnicas Analíticas Microfluídicas , Humanos , Reproducibilidad de los Resultados , Programas Informáticos
8.
Nature ; 474(7351): 350-5, 2011 Jun 15.
Artículo en Inglés | MEDLINE | ID: mdl-21677752

RESUMEN

Asparagine-linked glycosylation is a post-translational modification of proteins containing the conserved sequence motif Asn-X-Ser/Thr. The attachment of oligosaccharides is implicated in diverse processes such as protein folding and quality control, organism development or host-pathogen interactions. The reaction is catalysed by oligosaccharyltransferase (OST), a membrane protein complex located in the endoplasmic reticulum. The central, catalytic enzyme of OST is the STT3 subunit, which has homologues in bacteria and archaea. Here we report the X-ray structure of a bacterial OST, the PglB protein of Campylobacter lari, in complex with an acceptor peptide. The structure defines the fold of STT3 proteins and provides insight into glycosylation sequon recognition and amide nitrogen activation, both of which are prerequisites for the formation of the N-glycosidic linkage. We also identified and validated catalytically important, acidic amino acid residues. Our results provide the molecular basis for understanding the mechanism of N-linked glycosylation.


Asunto(s)
Campylobacter lari/enzimología , Hexosiltransferasas/química , Proteínas de la Membrana/química , Amidas/metabolismo , Secuencias de Aminoácidos , Asparagina/química , Asparagina/genética , Asparagina/metabolismo , Dominio Catalítico , Cristalografía por Rayos X , Glicosilación , Hexosiltransferasas/genética , Hexosiltransferasas/metabolismo , Proteínas de la Membrana/genética , Proteínas de la Membrana/metabolismo , Modelos Moleculares , Nitrógeno/metabolismo , Unión Proteica , Estructura Terciaria de Proteína , Relación Estructura-Actividad , Especificidad por Sustrato
9.
Nat Chem Biol ; 6(4): 264-6, 2010 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-20190762

RESUMEN

We describe a new method for producing homogeneous eukaryotic N-glycoproteins. The method involves the engineering and functional transfer of the Campylobacter jejuni glycosylation machinery in Escherichia coli to express glycosylated proteins with the key GlcNAc-Asn linkage. The bacterial glycans were then trimmed and remodeled in vitro by enzymatic transglycosylation to fulfill a eukaryotic N-glycosylation. It provides a potentially general platform for producing eukaryotic N-glycoproteins.


Asunto(s)
Eucariontes/metabolismo , Ingeniería Genética , Glicoproteínas/biosíntesis , Glicosilación , Campylobacter jejuni/genética , Campylobacter jejuni/metabolismo , Escherichia coli/genética , Escherichia coli/metabolismo , Eucariontes/química , Glicoproteínas/química
10.
J Am Chem Soc ; 131(3): 1274-81, 2009 Jan 28.
Artículo en Inglés | MEDLINE | ID: mdl-19154179

RESUMEN

Although there is great interest in three-dimensional structures of glycoproteins and complex oligosaccharides, their structural determination have been hampered by inhomogeneous and incomplete glycosylation, poor expression, low tendency to crystallize, and severe chemical shift overlap. Using segmental labeling of the glycan and the protein component by in vitro glycosylation, we developed a novel method of NMR structural determination that overcomes some of these problems. Highly homogeneously glycosylated proteins in milligram amounts can be obtained. This allowed the determination of the structure of an N-linked glycoprotein from Campylobacter jejuni. The glycosylation acceptor site was found to be in a flexible loop. The presented methodology extends the observable NOE distance limit of oligosaccharides significantly over 4 A, resulting in a high number of distance restraints per glycosidic linkage. A well-defined glycan structure was obtained.


Asunto(s)
Glicoproteínas/análisis , Glicoproteínas/química , Espectroscopía de Resonancia Magnética/métodos , Secuencia de Aminoácidos , Campylobacter jejuni/química , Glicosilación , Modelos Moleculares , Estructura Terciaria de Proteína , Estereoisomerismo
11.
Science ; 314(5802): 1148-50, 2006 Nov 17.
Artículo en Inglés | MEDLINE | ID: mdl-17110579

RESUMEN

N-linked protein glycosylation is found in all domains of life. In eukaryotes, it is the most abundant protein modification of secretory and membrane proteins, and the process is coupled to protein translocation and folding. We found that in bacteria, N-glycosylation can occur independently of the protein translocation machinery. In an in vitro assay, bacterial oligosaccharyltransferase glycosylated a folded endogenous substrate protein with high efficiency and folded bovine ribonuclease A with low efficiency. Unfolding the eukaryotic substrate greatly increased glycosylation. We propose that in the bacterial system, glycosylation sites are located in flexible parts of folded proteins, whereas the eukaryotic cotranslational glycosylation evolved to a mechanism presenting the substrate in a flexible form before folding.


Asunto(s)
Proteínas Bacterianas/metabolismo , Glicoproteínas/metabolismo , Pliegue de Proteína , Secuencia de Aminoácidos , Animales , Campylobacter jejuni , Bovinos , Escherichia coli , Glicosilación , Hexosiltransferasas/metabolismo , Proteínas de la Membrana/metabolismo , Datos de Secuencia Molecular , Transporte de Proteínas , Proteínas Recombinantes/metabolismo
12.
EMBO J ; 25(9): 1957-66, 2006 May 03.
Artículo en Inglés | MEDLINE | ID: mdl-16619027

RESUMEN

The Campylobacter jejuni pgl locus encodes an N-linked protein glycosylation machinery that can be functionally transferred into Escherichia coli. In this system, we analyzed the elements in the C. jejuni N-glycoprotein AcrA required for accepting an N-glycan. We found that the eukaryotic primary consensus sequence for N-glycosylation is N terminally extended to D/E-Y-N-X-S/T (Y, X not equalP) for recognition by the bacterial oligosaccharyltransferase (OST) PglB. However, not all consensus sequences were N-glycosylated when they were either artificially introduced or when they were present in non-C. jejuni proteins. We were able to produce recombinant glycoproteins with engineered N-glycosylation sites and confirmed the requirement for a negatively charged side chain at position -2 in C. jejuni N-glycoproteins. N-glycosylation of AcrA by the eukaryotic OST in Saccharomyces cerevisiae occurred independent of the acidic residue at the -2 position. Thus, bacterial N-glycosylation site selection is more specific than the eukaryotic equivalent with respect to the polypeptide acceptor sequence.


Asunto(s)
Proteínas Bacterianas/química , Proteínas Bacterianas/metabolismo , Campylobacter jejuni/metabolismo , Glicoproteínas/química , Glicoproteínas/metabolismo , Secuencia de Aminoácidos/genética , Sustitución de Aminoácidos/genética , Aminoácidos/química , Aminoácidos/genética , Aminoácidos/metabolismo , Proteínas de la Membrana Bacteriana Externa/química , Proteínas de la Membrana Bacteriana Externa/genética , Proteínas de la Membrana Bacteriana Externa/metabolismo , Proteínas Bacterianas/genética , Secuencia de Consenso/genética , Glicoproteínas/genética , Glicosilación , Hexosiltransferasas/metabolismo , Lipoproteínas/química , Lipoproteínas/genética , Lipoproteínas/metabolismo , Proteínas de la Membrana/metabolismo , Datos de Secuencia Molecular , Mutación , Saccharomyces cerevisiae/metabolismo
13.
Chem Biol ; 12(12): 1311-5, 2005 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-16356848

RESUMEN

The gram-negative bacterium Campylobacter jejuni has a general N-linked glycosylation pathway encoded by the pgl gene cluster. One of the proteins in this cluster, PgIB, is thought to be the oligosaccharyl transferase due to its significant homology to Stt3p, a subunit of the yeast oligosaccharyl transferase complex. PgIB has been shown to be involved in catalyzing the transfer of an undecaprenyl-linked heptasaccharide to the asparagine side chain of proteins at the Asn-X-Ser/Thr motif. Using a synthetic disaccharide glycan donor (GaINAc-alpha1,3-bacillosamine-pyrophosphate-undecaprenyl) and a peptide acceptor substrate (KDFNVSKA), we can observe the oligosaccharyl transferase activity of PgIB in vitro. Furthermore, the preparation of additional undecaprenyl-linked glycan variants reveals the ability of PgIB to transfer a wide variety of saccharides. With the demonstration of PgIB activity in vitro, fundamental questions surrounding the mechanism of N-linked glycosylation can now be addressed.


Asunto(s)
Proteínas Bacterianas/metabolismo , Campylobacter jejuni/genética , Glicopéptidos/biosíntesis , Glicosiltransferasas/metabolismo , Hexosiltransferasas/metabolismo , Proteínas de la Membrana/metabolismo , Péptidos/síntesis química , Secuencia de Aminoácidos , Proteínas Bacterianas/química , Campylobacter jejuni/enzimología , Escherichia coli/genética , Glicosiltransferasas/química , Hexosiltransferasas/química , Proteínas de la Membrana/química , Datos de Secuencia Molecular , Estructura Molecular , Alineación de Secuencia , Especificidad por Sustrato , Regulación hacia Arriba
14.
Biochemistry ; 44(9): 3347-57, 2005 Mar 08.
Artículo en Inglés | MEDLINE | ID: mdl-15736945

RESUMEN

A mechanistic study of the poorly understood pathway by which the inhibitor acarbose is enzymatically rearranged by human pancreatic alpha-amylase has been conducted by structurally examining the binding modes of the related inhibitors isoacarbose and acarviosine-glucose, and by novel kinetic measurements of all three inhibitors under conditions that demonstrate this rearrangement process. Unlike acarbose, isoacarbose has a unique terminal alpha-(1-6) linkage to glucose and is found to be resistant to enzymatic rearrangement. This terminal glucose unit is found to bind in the +3 subsite and for the first time reveals the interactions that occur in this part of the active site cleft with certainty. These results also suggest that the +3 binding subsite may be sufficiently flexible to bind the alpha-(1-6) branch points in polysaccharide substrates, and therefore may play a role in allowing efficient cleavage in the direct vicinity of such junctures. Also found to be resistant to enzymatic rearrangement was acarviosine-glucose, which has one fewer glucose unit than acarbose. Collectively, structural studies of all three inhibitors and the specific cleavage pattern of HPA make it possible to outline the simplest sequence of enzymatic reactions likely involved upon acarbose binding. Prominent features incorporated into the starting structure of acarbose to facilitate the synthesis of the final tightly bound pseudo-pentasaccharide product are the restricted availability of hydrolyzable bonds and the placement of the transition state-like acarviosine group. Additional "in situ" experiments designed to elongate and thereby optimize isoacarbose and acarviosine-glucose inhibition using the activated substrate alphaG3F demonstrate the feasibility of this approach and that the principles outlined for acarbose rearrangement can be used to predict the final products that were obtained.


Asunto(s)
Acarbosa/química , Acarbosa/metabolismo , Inhibidores Enzimáticos/química , Inhibidores Enzimáticos/metabolismo , Páncreas/enzimología , alfa-Amilasas/antagonistas & inhibidores , alfa-Amilasas/química , Acarbosa/análogos & derivados , Amino Azúcares/biosíntesis , Amino Azúcares/química , Sitios de Unión , Catálisis , Cristalografía por Rayos X , Humanos , Hidrólisis , Cinética , Oligosacáridos/biosíntesis , Oligosacáridos/química , Especificidad por Sustrato , alfa-Amilasas/metabolismo
15.
Protein Sci ; 14(3): 743-55, 2005 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-15722449

RESUMEN

The mechanism of allosteric activation of alpha-amylase by chloride has been studied through structural and kinetic experiments focusing on the chloride-dependent N298S variant of human pancreatic alpha-amylase (HPA) and a chloride-independent TAKA-amylase. Kinetic analysis of the HPA variant clearly demonstrates the pronounced activating effect of chloride ion binding on reaction rates and its effect on the pH-dependence of catalysis. Structural alterations observed in the N298S variant upon chloride ion binding suggest that the chloride ion plays a variety of roles that serve to promote catalysis. One of these is having a strong influence on the positioning of the acid/base catalyst residue E233. Absence of chloride ion results in multiple conformations for this residue and unexpected enzymatic products. Chloride ion and N298 also appear to stabilize a helical region of polypeptide chain from which projects the flexible substrate binding loop unique to chloride-dependent alpha-amylases. This structural feature also serves to properly orient the catalytically essential residue D300. Comparative analyses show that the chloride-independent alpha-amylases compensate for the absence of bound chloride by substituting a hydrophobic core, altering the manner in which substrate interactions are made and shifting the placement of N298. These evolutionary differences presumably arise in response to alternative operating environments or the advantage gained in a particular product profile. Attempts to engineer chloride-dependence into the chloride-independent TAKA-amylase point out the complexity of this system, and the fact that a multitude of factors play a role in binding chloride ion in the chloride-dependent alpha-amylases.


Asunto(s)
Cloruros/metabolismo , Páncreas/enzimología , alfa-Amilasas/química , Acarbosa/metabolismo , Secuencia de Aminoácidos , Sustitución de Aminoácidos , Aspergillus oryzae/enzimología , Aspergillus oryzae/genética , Activación Enzimática/fisiología , Humanos , Enlace de Hidrógeno , Cinética , Mutagénesis , Páncreas/metabolismo , Estructura Terciaria de Proteína , Alineación de Secuencia , alfa-Amilasas/genética , alfa-Amilasas/metabolismo
16.
J Biol Chem ; 279(46): 48282-91, 2004 Nov 12.
Artículo en Inglés | MEDLINE | ID: mdl-15304511

RESUMEN

A new approach for the discovery and subsequent structural elucidation of oligosaccharide-based inhibitors of alpha-amylases based upon autoglucosylation of known alpha-glucosidase inhibitors is presented. This concept, highly analogous to what is hypothesized to occur with acarbose, is demonstrated with the known alpha-glucosidase inhibitor, d-gluconohydroximino-1,5-lactam. This was transformed from an inhibitor of human pancreatic alpha-amylase with a K(i) value of 18 mm to a trisaccharide analogue with a K(i) value of 25 mum. The three-dimensional structure of this complex was determined by x-ray crystallography and represents the first such structure determined with this class of inhibitors in any alpha-glycosidase. This approach to the discovery and structural analysis of amylase inhibitors should be generally applicable to other endoglucosidases and readily adaptable to a high throughput format.


Asunto(s)
Diseño de Fármacos , Inhibidores Enzimáticos , Trisacáridos , alfa-Amilasas/antagonistas & inhibidores , alfa-Amilasas/química , Acarbosa/síntesis química , Acarbosa/química , Acarbosa/metabolismo , Animales , Sitios de Unión , Secuencia de Carbohidratos , Cristalografía por Rayos X , Inhibidores Enzimáticos/síntesis química , Inhibidores Enzimáticos/química , Inhibidores Enzimáticos/metabolismo , Humanos , Modelos Moleculares , Estructura Molecular , Páncreas/enzimología , Unión Proteica , Estructura Terciaria de Proteína , Trisacáridos/síntesis química , Trisacáridos/química , Trisacáridos/metabolismo , alfa-Amilasas/metabolismo
17.
Carbohydr Res ; 339(10): 1727-37, 2004 Jul 12.
Artículo en Inglés | MEDLINE | ID: mdl-15220082

RESUMEN

Derivatives of maltose and maltotriose were chemically synthesised as substrates for human pancreatic alpha-amylases and subjected to kinetic analysis. Rates measured were shown to reflect both hydrolysis and transglycosylation reactions. 4-O-Methylated derivatives of these substrates underwent only hydrolysis, thereby simplifying kinetic analyses. These modified substrates may be used for the detection and kinetic analysis of alpha-amylases, and are useful in rapidly screening for novel alpha-amylase inhibitors and for subsequent kinetic characterisation.


Asunto(s)
Páncreas/enzimología , alfa-Amilasas/química , Bioquímica/métodos , Cromatografía Líquida de Alta Presión , Inhibidores Enzimáticos/farmacología , Glicosilación , Humanos , Concentración de Iones de Hidrógeno , Hidrólisis , Cinética , Modelos Químicos , Espectrofotometría , Especificidad por Sustrato , Temperatura , Factores de Tiempo , Rayos Ultravioleta , alfa-Amilasas/antagonistas & inhibidores
18.
J Biol Chem ; 278(48): 48074-83, 2003 Nov 28.
Artículo en Inglés | MEDLINE | ID: mdl-12960159

RESUMEN

The family 38 golgi alpha-mannosidase II, thought to cleave mannosidic bonds through a double displacement mechanism involving a reaction intermediate, is a clinically important enzyme involved in glycoprotein processing. The structure of three different covalent glycosyl-enzyme intermediates have been determined to 1.2-A resolution for the Golgi alpha-mannosidase II from Drosophila melanogaster by use of fluorinated sugar analogues, both with the wild-type enzyme and a mutant enzyme in which the acid/base catalyst has been removed. All these structures reveal sugar intermediates bound in a distorted 1S5 skew boat conformation. The similarity of this conformation with that of the substrate in the recently determined structure of the Michaelis complex of a beta-mannanase (Ducros, V. M. A., Zechel, D. L., Murshudov, G. N., Gilbert, H. J., Szabo, L., Stoll, D., Withers, S. G., and Davies, G. J. (2002) Angew. Chem. Int. Ed. Engl. 41, 2824-2827) suggests that these disparate enzymes have recruited common stereoelectronic features in evolving their catalytic mechanisms.


Asunto(s)
Drosophila melanogaster/fisiología , Aparato de Golgi/enzimología , Manosidasas/fisiología , Animales , Conformación de Carbohidratos , Catálisis , Cristalografía por Rayos X , Relación Dosis-Respuesta a Droga , Drosophila melanogaster/metabolismo , Electrones , Cinética , Manosidasas/metabolismo , Espectrometría de Masas , Modelos Químicos , Modelos Moleculares , Mutación , Unión Proteica , Factores de Tiempo , beta-Manosidasa/química
19.
Biochemistry ; 41(1): 215-25, 2002 Jan 08.
Artículo en Inglés | MEDLINE | ID: mdl-11772019

RESUMEN

Human pancreatic alpha-amylase (HPA) is a member of the alpha-amylase family involved in the degradation of starch. Some members of this family, including HPA, require chloride for maximal activity. To determine the mechanism of chloride activation, a series of mutants (R195A, R195Q, N298S, R337A, and R337Q) were made in which residues in the chloride ion binding site were replaced. Mutations in this binding site were found to severely affect the ability of HPA to bind chloride ions with no binding detected for the R195 and R337 mutant enzymes. X-ray crystallographic analysis revealed that these mutations did not result in significant structural changes. However, the introduction of these mutations did alter the kinetic properties of the enzyme. Mutations to residue R195 resulted in a 20-450-fold decrease in the activity of the enzyme toward starch and shifted the pH optimum to a more basic pH. Interestingly, replacement of R337 with a nonbasic amino acid resulted in an alpha-amylase that no longer required chloride for catalysis and has a pH profile similar to that of wild-type HPA. In contrast, a mutation at residue N298 resulted in an enzyme that had much lower binding affinity for chloride but still required chloride for maximal activity. We propose that the chloride is required to increase the pK(a) of the acid/base catalyst, E233, which would otherwise be lower due to the presence of R337, a positively charged residue.


Asunto(s)
Cloruros/fisiología , Páncreas/enzimología , alfa-Amilasas/metabolismo , Secuencia de Bases , Sitios de Unión , Cristalización , Escherichia coli/enzimología , Humanos , Cinética , Modelos Químicos , Datos de Secuencia Molecular , Mutación
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...